Bajaj Healthcare
BSE 539872
8 stories, newest first.
- Bajaj Healthcare uploads audio recording of Q2 & H1 FY27 earnings call held October 19, 2026
- Q2 FY27 release: revenue up 18.9% YoY to Rs. 175.9 Crore, PAT up 26.9%, credit rating upgraded
- Monitoring agency report: nil deviation in use of Rs. 204.97 crore preferential issue proceeds
- Board approves Q2 results with unmodified review; NCLT clears Genxrx acquisition
- NCLT approves acquisition of Genrx Pharmaceuticals on a going concern basis
- Bajaj Healthcare earnings call for Q2 & H1 FY27 on October 19, 2026 at 5:00 PM IST
- Deed of Assignment executed to sell Dahej undertaking for about Rs. 14.67 crore
- Board meeting on 17 October 2026 to consider un-audited results for Q2 and H1
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.